Spin-offs
Company spin-offs from ETH are one direct and very effective form of technology and knowledge transfer that boost the innovative strength of Switzerland's economy. These newly established small companies can be relied upon to convert the fruits of research into marketable products more quickly than large companies, opening up new markets in the process.
The latest articles about our spin-offs
D-ITET spin-off UNOMR wins prestigious Hello Tomorrow Challenge
UNOMR has won the “Digital Health & Medical Devices” track of the 2026 Hello Tomorrow Challenge in Amsterdam. The D-ITET spin-off was recognised for pushing the boundaries of what protein analysis can do.
Marvell acquires Polariton to strengthen optical performance
Marvell Technology has completed the acquisition of Polariton Technologies Ltd., a Swiss company in the field of plasmonics. The D-ITET spin-off is set to bring deep silicon photonics expertise to the US company.
“We are addressing a ‘blind spot’ in biology and medicine”: How UNOMR makes proteins readable
Proteins are the building blocks of life, yet until now they have been difficult for researchers to read. The D-ITET spin-off UNOMR aims to close this gap with a novel sequencing technology. We spoke with Dr Til Schlotter and Dr Julian Hengsteler about their vision and why working in the cleanroom is a bit like cooking.
D-ITET’s culture of innovation has resulted in a total of 83 spin-offs to date (as of Q4 2025), translating world-class research into market-leading solutions.
Information for ETH community
For more information about setting up an ETH spin-off company, please contact the folloing Websites: